Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Stibogluconate for Leishmaniasis
NCT00662012Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Jun 2002
- Primary completion
- Oct 2007
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of sodium stibogluconate in leishmaniasis, sponsored by U.S. Army Medical Research and Development Command. Started Jun 2002; status: completed.
02
Drugs
sodium stibogluconate
03
Conditions
leishmaniasis
Beyond the preview
Go deeper on NCT00662012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00662012.